BioCryst to Report First Quarter 2023 Financial Results on May 3
RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2023 financial results on Wednesday, May 3, 2023.
Related news for (BCRX)
- BioCryst Buys Growth, STRATA Shines in Rare Cancer, and Spider Silk Soars
- Breaking News: MoBot’s Latest Update as of 05/05/25 03:00 PM
- Today’s Top Performers: MoBot’s Market Review 05/05/25 02:00 PM
- BioCryst Pharmaceuticals Soars with Stellar Q1 2025 Results, Raises ORLADEYO Guidance, and Achieves Profitability Ahead of Schedule
- BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update